Dr. Scott Gottlieb Says Feds to Blame for Merck Pill Delays into 2022: ‘This is the Government'
Added 10-11-21 01:34:03pm EST - “Former Food and Drug Administration chief Dr. Scott Gottlieb said he faulted the federal government for delays likely to prevent Merck's Covid-19 pill from reaching the market until 2022.” - Mediaite.com
CLICK TO SHARE
Former Food and Drug Administration chief Dr. Scott Gottlieb said Monday he faults the federal government for delays that were likely to prevent Merck’s Covid-19 pill from reaching the market until 2022.
Merck on Monday submitted an application to the FDA for an Emergency Use Authorization enabling distribution of its Covid-19 drug, molnupiravir, to treat patients who have the virus. However, Gottlieb said that regardless of his former agency’s decision, it was unlikely the pill would reach a wide swath of the market before 2022.
“The … lament is that we didn’t have more investment early on in trying to scale up the manufacturing of the drug, so we’re going to have a limited supply if this does come to the market before the end of the year,” Gottlieb said in an interview with CNBC’s Joe Kernen. “It’s hard for me to decouple what what impact the government issues here that you’re talking about had on this.”
“There was a focus on the vaccines and there wasn’t enough focus on the therapeutics and trying to get the available manufacturing,” he said. “That’s where the government really could have played a role.”
“I think the government could have done much more with scaling up manufacturing, so we’d have excess capacity if one of these drugs was successful. That’s the problem,” he said.
If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.
CLICK TO SHARE